norethindrone has been researched along with Atherogenesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Athanasopoulos, N; Creatsas, G; Deligeoroglou, E; Economou, E; Lambrinoudaki, I; Mastorakos, G; Papamichael, C; Rizos, D; Stamatelopoulos, K; Tsimaris, P | 1 |
| Ceylan, E; Inan, S; Koyuncu, FM; Kuscu, NK; Ozbilgin, K; Vatansever, S | 1 |
| Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA | 1 |
| Barton, M; Haas, E; Meyer, MR | 1 |
1 trial(s) available for norethindrone and Atherogenesis
| Article | Year |
|---|---|
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2007 |
3 other study(ies) available for norethindrone and Atherogenesis
| Article | Year |
|---|---|
The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46,XY DSD individuals with female phenotype.
Topics: Adolescent; Adult; Androgen-Insensitivity Syndrome; Atherosclerosis; Drug Combinations; Endothelium, Vascular; Estradiol; Estrogens; Female; Gonadal Dysgenesis, 46,XY; Humans; Male; Norethindrone; Norethindrone Acetate; Progestins; Treatment Outcome; Ultrasonography; Young Adult | 2014 |
The effect of oestradiol and neta on immunohistochemical staining of iNOS and eNOS in coronary arteries of ovariectomized rats.
Topics: Animals; Atherosclerosis; Connective Tissue; Coronary Vessels; Down-Regulation; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Immunohistochemistry; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norethindrone; Norethindrone Acetate; Ovariectomy; Rats; Rats, Wistar | 2006 |
Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?
Topics: Age Factors; Aged; Aging; Atherosclerosis; Coronary Artery Disease; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Incidence; Middle Aged; Norethindrone; Postmenopause; Prognosis; Risk Factors; Treatment Outcome | 2007 |